Apelin detection kit and detection method

Through the development of the Apelin detection kit, non-invasive testing is carried out using the principle of biochemical reactions, solving the invasiveness and complexity of surgical operations in DR detection, achieving low-cost and low-risk early screening and prevention, and improving Patient safety and testing efficiency.

CN119064598APending Publication Date: 2024-12-03XIAMEN EYE CENTER OF XIAMEN UNIVERSITY CO LTD
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202411331879.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2024-09-24
Publication Date
2024-12-03

AI Technical Summary

Technical Problem

The existing diabetic retinopathy (DR) detection methods have invasiveness of surgical operations, complication risks, patient discomfort and compliance, as well as the complexity and high cost of the detection process, resulting in greater room for improvement in clinical applications, especially in reducing invasive procedures and improving patient safety.

Method used

A Apelin detection kit was developed to use specific biochemical reaction principles to detect through the steps of sample preparation, reagent addition, reaction and incubation, signal detection and result interpretation, to avoid surgical operations, and use reagents containing Apelin receptors. A specific reaction with Apelin in the sample produces observable signals for qualitative or quantitative detection.

Benefits of technology

It provides a convenient, fast and low-risk detection method that can predict DR and provides a reference for early prevention of diabetes, reduces medical resource costs, improves the efficiency of early screening, and reduces the complexity of early detection.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN119064598A_ABST
    Figure CN119064598A_ABST
Patent Text Reader

Abstract

The invention belongs to the technical field of detection kits, and discloses an Apelin detection kit, which is convenient and rapid, can be used for detection by taking blood, avoids risks caused by surgical operations, and relieves psychological stress reactions such as emotional tension caused when a patient enters an operating room. The detection kit works based on a specific biochemical reaction principle. According to the method, a reagent containing an apelin receptor and apelin in a sample to be detected are subjected to specific reaction, so that an observable signal is generated. The signal can be shown by means of color change, fluorescence intensity and the like, so that qualitative or quantitative detection of a target substance is realized.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention belongs to the technical field of detection kits, and in particular relates to an Apelin detection kit. Background Art

[0002] Diabetic retinopathy (DR), as a common complication of diabetes, is one of the major eye diseases that cause blindness worldwide. The incidence of DR has increased year by year and has become a global public health issue, imposing a serious burden on the social economy. In the early stages of DR, there are manifestations of retinal vascular damage, including destruction of the blood-retinal barrier, increased vascular permeability, endothelial cell proliferation, pericyte reduction, basement membrane thickening, etc. As the disease progresses, complications such as neovascularization, vitreous hemorrhage, macular edema, and retinal detachment may occur, seriously affecting visual function.

[0003] At present, the treatment of DR mainly includes laser therapy, drug therapy and surgical treatment. Laser therapy involves methods such as panretinal photocoagulation, local photocoagulation and grid photocoagulation; drug therapy includes the application of glucocorticoids and intravitreal injection of anti-vascular endothelial growth factor (VEGF); surgical treatment mainly involves vitrectomy. However, although these treatments can relieve symptoms, they cannot fundamentally solve the core problems such as microvascular non-perfusion and ischemia and hypoxia, and there are certain treatment limitations and side effects. Therefore, in order to more effectively diagnose and intervene in diabetic retinopathy, the development of sensitive and easy-to-use detection markers is of vital clinical value.

[0004] The progression of diabetic retinopathy (DR) is unpredictable, so specific test kits are needed to assess the risk of DR and guide clinical diagnosis and treatment. DR detection and analysis requires the collection of intraocular fluid, and surgical operations have certain adverse reactions and complications.

[0005] The search found that in 2021, there was an invention in China involving a biomarker for the detection of diabetic retinopathy and a corresponding detection kit (CN111793683B). This kit uses real-time fluorescence quantitative PCR technology to detect the relative content of LncRNA AQP4-AS1 in serum, providing a new detection marker and prognosis evaluation method for diabetic retinopathy. Apelin is a relatively active regulatory factor in recent years. It is related to vascular endothelial cell proliferation and pathological angiogenesis. Our team has been committed to studying the role of Apelin and DR for more than 10 years, exploring the important role of Apelin in protecting pericytes in the early stage of DR to reduce vascular leakage and promoting neovascularization in the late stage. And a large number of studies have shown that it is not only involved in the regulation of cardiovascular system diseases, sugar metabolism, and lipid metabolism, but also in a variety of cell activities, such as cell proliferation, migration, apoptosis, and inflammatory response. Bilir et al. found in human experiments that the concentration of Apelin in the blood of patients with diabetic peripheral neuropathy was higher than that of those with diabetes but no peripheral neuropathy. It is speculated that Apelin may be involved in the regulation of the pathogenesis of some diabetic peripheral neuropathy. In view of the important role of Apelin in diabetes, our team intends to invent an Apelin detection kit for the prediction of DR.

[0006] The problems and defects of existing technologies in the detection of diabetic retinopathy (DR) are mainly reflected in the following aspects:

[0007] 1. Invasiveness of surgical procedures: DR testing usually requires the collection of intraocular fluid, which is an invasive procedure that may cause adverse reactions in patients, such as intraocular inflammation and decreased vision.

[0008] 2. Risk of complications: Due to the complexity of the operation, intraocular fluid collection may cause a series of complications, including infection, bleeding, increased intraocular pressure, etc., which increases the patient's treatment risk and difficulty of postoperative recovery.

[0009] 3. Patient discomfort and compliance: Invasive testing methods may cause fear and discomfort in patients, which in turn affects their treatment compliance and hinders early detection and intervention of the disease.

[0010] 4. Complexity and cost of the detection process: Existing detection methods usually require professional equipment and personnel to operate, which increases the complexity and cost of the detection process and is not conducive to widespread promotion and early screening.

[0011] These problems indicate that there is much room for improvement in the clinical application of existing DR detection technology, especially in reducing invasive procedures and improving patient safety. Summary of the invention

[0012] In view of the problems existing in the prior art, the present invention provides an Apelin detection kit.

[0013] The present invention is achieved in that an Apelin detection kit detection method comprises:

[0014] Step 1, sample preparation:

[0015] Collect samples to be tested according to the instructions; extract samples from organisms or the environment and place them in dedicated sample tubes;

[0016] Step 2, reagent addition:

[0017] Take out the corresponding reagents from the kit and add them to the sample tube according to the instructions in the instruction manual;

[0018] Step 3, reaction and incubation;

[0019] Step 4, signal detection;

[0020] Step 5: Interpretation of results.

[0021] Furthermore, the organism includes blood and urine.

[0022] Furthermore, the reagent is usually pre-formulated, has specific chemical properties, and reacts with the target substance in the sample.

[0023] Further, the reaction and incubation:

[0024] After the reagents and samples are mixed, they need to be placed under appropriate conditions for reaction and incubation; the temperature and time parameters must be controlled to ensure that the reaction proceeds fully.

[0025] Further, the signal detection:

[0026] After the reaction is completed, the presence of the target substance can be determined by observing the color change and fluorescence intensity signal in the sample tube.

[0027] Further, the results are interpreted as follows:

[0028] Interpret the test results according to the standard curve or control table in the instructions; by comparing with the standard value, the concentration or activity level of the target substance in the sample can be determined, and the corresponding conclusion can be drawn.

[0029] Another object of the present invention is to provide an Apelin detection kit detection system comprising:

[0030] The sample preparation module is used to collect samples to be tested according to the requirements of the instructions; extract samples from organisms or the environment and place them in dedicated sample tubes;

[0031] A reagent adding module, used to take out the corresponding reagent from the reagent kit and add it to the sample tube according to the instructions of the instruction manual;

[0032] The reaction and incubation module is used to place the reagents and samples under appropriate conditions for reaction and incubation after mixing; control the temperature and time parameters to ensure that the reaction proceeds fully;

[0033] The signal detection module is used to determine the presence of the target substance by observing the color change and fluorescence intensity signal in the sample tube after the reaction is completed;

[0034] The result interpretation module is used to interpret the test results according to the standard curve or reference table in the instruction manual; by comparing with the standard value, the concentration or activity level of the target substance in the sample can be determined, thereby drawing corresponding conclusions.

[0035] Another object of the present invention is to provide a computer device, which includes a memory and a processor, wherein the memory stores a computer program, and when the computer program is executed by the processor, the processor executes the steps of the Apelin detection kit detection method.

[0036] Another object of the present invention is to provide a computer-readable storage medium storing a computer program, wherein when the computer program is executed by a processor, the processor executes the steps of the detection method of the Apelin detection kit.

[0037] Another object of the present invention is to provide an information data processing terminal, which is used to implement the Apelin detection kit detection system.

[0038] In combination with the above technical solutions and the technical problems solved, the advantages and positive effects of the technical solutions to be protected by the present invention are as follows:

[0039] First, the detection kit provided by the present invention is convenient and quick, and can be tested by taking blood, thus avoiding the risks brought by surgical operations and reducing the psychological stress reactions such as emotional tension caused by patients entering the operating room.

[0040] The detection kit of the present invention works based on a specific biochemical reaction principle. It uses a reagent containing apelin receptor to react specifically with apelin in the sample to be tested, thereby generating an observable signal. This signal can be expressed in the form of color change, fluorescence intensity, etc., thereby achieving qualitative or quantitative detection of the target substance.

[0041] Second, as auxiliary evidence of the inventiveness of the claims of the present invention, it is also reflected in the following important aspects:

[0042] (1) The expected benefits and commercial value of the technical solution of the present invention after transformation are:

[0043] The Apelin detection kit can not only predict DR, but also provide a reference for the development of diabetes. In the future, it may guide the early prevention of diabetes and more conveniently achieve early detection, early diagnosis and early treatment. Through the detection of the kit, it can greatly save the cost of medical resources and reduce a large number of cumbersome hematology and imaging tests in the early stage, which is of great help to early screening.

[0044] (2) Whether the technical solution of the present invention solves the technical problems that people have been eager to solve but have never been able to solve successfully:

[0045] Currently, there is no detection method that can be used to predict DR. The present invention hopes to complete DR prediction through hematological detection and solve clinical problems. BRIEF DESCRIPTION OF THE DRAWINGS

[0046] Figure 1 The present invention provides an Apelin detection kit detection method flow chart.

[0047] Figure 2 It is a structural block diagram of the detection system of the Apelin detection kit provided in an embodiment of the present invention.

[0048] Figure 3 It is an example diagram of a box plot of the detection result provided by an embodiment of the present invention.

[0049] Figure 4 This is an example of a box scatter plot of the detection results provided by an embodiment of the present invention.

[0050] Figure 5 This is an example diagram of a scatter plot of the detection results provided by an embodiment of the present invention.

[0051] Figure 6 A: color fundus images and SD-OCT photos of DME patients and normal subjects provided by the embodiments of the present invention; B: Western blot analysis of apelin expression in the vitreous humor of DME and ERM patients.

[0052] Figure 7 This is a diagram showing that Apelin provided by an embodiment of the present invention promotes the production of extracellular matrix in Muller cells cultured in high glucose.

[0053] Figure 8 This is a diagram showing that knocking down apelin inhibits the production of extracellular matrix in Muller cells cultured in high glucose, as provided in an embodiment of the present invention.

[0054] Fig. 9Apelin provided in an embodiment of the present invention regulates Muller cells cultured in high glucose via JAK2 / STAT3, rather than Wnt / β-catenin or NFκB signaling pathways.

[0055] Fig.10 This is a diagram showing that Apelin provided by an embodiment of the present invention promotes the phosphorylation level of cell markers and proteins of the JAK2 / STAT3 signaling pathway of Muller cells cultured in high glucose.

[0056] Fig.11 Apelin provided in an embodiment of the present invention promotes retinal fibrosis formation in DM rats, and the levels of Muller cell markers and fibrosis markers are significantly increased.

[0057] Fig.12 This is a diagram showing that knocking down apelin inhibits the production of Muller cell markers and extracellular matrix in DM rats as provided in an embodiment of the present invention. DETAILED DESCRIPTION

[0058] In order to make the purpose, technical solution and advantages of the present invention more clearly understood, the present invention is further described in detail below in conjunction with the embodiments. It should be understood that the specific embodiments described herein are only used to explain the present invention and are not used to limit the present invention.

[0059] like Figure 1 As shown, an Apelin detection kit detection method provided by an embodiment of the present invention comprises the following steps:

[0060] S101, Sample preparation:

[0061] Collect samples to be tested according to the instructions; extract samples from organisms or the environment and place them in dedicated sample tubes;

[0062] S102, reagent addition:

[0063] Take out the corresponding reagents from the kit and add them to the sample tube according to the instructions in the instruction manual;

[0064] S103, reaction and incubation;

[0065] S104, signal detection;

[0066] S105, interpretation of results.

[0067] The detection method of the Apelin detection kit includes the following steps, each of which has a specific working principle to ensure the accuracy and reliability of the detection process.

[0068] First, the sample preparation stage (S101) is the basis of the entire detection process. According to the instructions of the kit instructions, the samples to be tested need to be collected first. These samples may come from organisms (such as blood, tissue or urine) or specific sources in the environment. After collection, the samples are transferred to dedicated sample tubes, which are pre-treated to ensure the integrity and stability of the samples, thereby providing accurate starting materials for subsequent detection steps.

[0069] Next is the reagent addition stage (S102), in which specific reagents provided in the kit are accurately added to the sample. These reagents usually contain antibodies, buffers or enzymes, which specifically bind or react with the Apelin protein in the sample. The process of adding reagents needs to be strictly followed in accordance with the instructions to ensure that the reaction conditions (such as pH, temperature and reagent concentration) are optimal to ensure the reliability of the test results.

[0070] Reaction and incubation (S103) are key steps in the test. The sample and reagent are incubated at a specific temperature to allow the reaction to proceed fully. During this process, the Apelin protein binds to the antibody in the reagent to form an antigen-antibody complex. This specific binding allows the Apelin protein to be labeled, usually through antibodies bound to enzymes or fluorescent molecules. Incubation time and conditions (such as temperature and length of time) must be strictly controlled to ensure complete reaction and reduce background noise.

[0071] Finally, the signal detection and result interpretation (S104 and S105) steps are the core part of the detection process. After the reaction is completed, the signal generated by the marker is measured by the detection device, such as by changes in light absorption or fluorescence intensity. The signal intensity is proportional to the concentration of Apelin in the sample. Finally, by quantitatively analyzing the detected signal, the test results are interpreted to determine the concentration of Apelin in the sample, thereby providing reliable data support for clinical diagnosis or research.

[0072] The organism provided in the embodiment of the present invention includes blood and urine.

[0073] The reagents provided in the embodiments of the present invention are usually pre-formulated, have specific chemical properties, and react with target substances in the sample.

[0074] The reaction and incubation provided by the embodiment of the present invention are as follows:

[0075] After the reagents and samples are mixed, they need to be placed under appropriate conditions for reaction and incubation; the temperature and time parameters must be controlled to ensure that the reaction proceeds fully.

[0076] The signal detection provided by the embodiment of the present invention:

[0077] After the reaction is completed, the presence of the target substance can be determined by observing the color change and fluorescence intensity signal in the sample tube.

[0078] Interpretation of the results provided by the embodiments of the present invention:

[0079] Interpret the test results according to the standard curve or control table in the instructions; by comparing with the standard value, the concentration or activity level of the target substance in the sample can be determined, and the corresponding conclusion can be drawn.

[0080] like Figure 2 As shown, an Apelin detection kit detection system provided by an embodiment of the present invention includes:

[0081] The sample preparation module is used to collect samples to be tested according to the requirements of the instructions; extract samples from organisms or the environment and place them in dedicated sample tubes;

[0082] A reagent adding module, used to take out the corresponding reagent from the reagent kit and add it to the sample tube according to the instructions of the instruction manual;

[0083] The reaction and incubation module is used to place the reagents and samples under appropriate conditions for reaction and incubation after mixing; control the temperature and time parameters to ensure that the reaction proceeds fully;

[0084] The signal detection module is used to determine the presence of the target substance by observing the color change and fluorescence intensity signal in the sample tube after the reaction is completed;

[0085] The result interpretation module is used to interpret the test results according to the standard curve or reference table in the instruction manual; by comparing with the standard value, the concentration or activity level of the target substance in the sample can be determined, thereby drawing corresponding conclusions.

[0086] Apelin detection kit detailed description

[0087] 1. Shape and structure

[0088] The Apelin test kit adopts a rectangular design with a simple and elegant appearance, which is easy to carry and store. Its size is about 15 cm long, 10 cm wide, and 3 cm high, and the weight is moderate, which is easy to hold and operate. The shell of the test kit is made of hard plastic material, which has good pressure resistance and drop resistance, ensuring that it is not easily damaged during transportation and use.

[0089] The inside of the test kit is finely divided into multiple areas, each of which is designed with a dedicated slot or groove for placing reagents, sample tubes, pipettes and other accessories required for testing. These accessories are cleverly fixed in their respective positions to ensure that they will not collide with each other or fall off during transportation and use.

[0090] 2. Working Principle

[0091] The test kit works based on a specific biochemical reaction principle. It uses a reagent containing apelin receptors to react specifically with apelin in the sample to be tested, thereby generating an observable signal. This signal can be expressed in the form of color change, fluorescence intensity, etc., thereby achieving qualitative or quantitative detection of the target substance.

[0092] 3. Working process

[0093] 1) Sample preparation: First, the user needs to collect the sample to be tested according to the instructions. This usually involves extracting the sample from an organism (such as blood, urine, etc.) or the environment and placing it in a dedicated sample tube.

[0094] 2) Reagent addition: Next, the user needs to take out the corresponding reagents from the kit and add them to the sample tube according to the instructions. These reagents are usually pre-formulated and have specific chemical properties that can react with the target substance in the sample.

[0095] 3) Reaction and incubation: After the reagents and samples are mixed, they need to be placed under appropriate conditions for reaction and incubation. This usually involves controlling parameters such as temperature and time to ensure that the reaction can proceed fully.

[0096] 4) Signal detection: After the reaction is completed, the user can determine the presence of the target substance by observing the color change, fluorescence intensity and other signals in the sample tube. Some kits are also equipped with dedicated detection equipment to measure the signal intensity more accurately, thereby achieving quantitative detection of the target substance.

[0097] 5) Interpretation of results: Finally, users need to interpret the test results based on the standard curve or reference table in the instructions. By comparing with the standard value, the concentration or activity level of the target substance in the sample can be determined, and the corresponding conclusion can be drawn.

[0098] The entire detection process is simple and fast, with high sensitivity and specificity, and is suitable for rapid detection needs in various occasions. At the same time, the design of the kit fully considers user experience and portability, allowing users to easily perform self-testing or on-site testing.

[0099] 4. Components

[0100] The test kit mainly consists of the following components:

[0101] 1) Shell: Made of hard plastic, it serves as the main structure of the test kit and protects internal components from damage.

[0102] 2) Reagent tank: located inside the shell, used to store reagent bottles or reagent strips to ensure the stability of the reagents during transportation and use.

[0103] 3) Sample slot: used to place sample tubes, usually designed with a fixing device to prevent the sample tubes from shaking or tipping over.

[0104] 4) Pipette or dropper: used to draw reagents from the reagent tank and add reagents to the sample tube in the sample tank.

[0105] 5) Reaction zone: A transparent area used to observe the reaction after the sample and reagent are mixed.

[0106] 6) Instructions: Provide detailed instructions for use, operating steps, interpretation of results, etc.

[0107] 5. Component location and connection relationship

[0108] 1) The housing is the basic structure, and other components are installed inside it. The top of the housing is usually designed with an opening and closing mechanism to facilitate users to take and put the internal components.

[0109] 2) The reagent tank and sample tank are usually set on both sides of the inner shell, which is convenient for users to operate reagents and samples at the same time. They are connected to the shell through a card slot or slot to ensure stability and not easy to fall off.

[0110] 3) The pipette or dropper is usually placed on the top or side of the test kit, so that the user can use it at any time. Some designs also have a fixing device on the pipette or dropper to prevent it from being lost.

[0111] 4) The reaction area is usually located above or beside the sample tank and is made of transparent material so that the user can clearly observe the reaction between the sample and the reagent.

[0112] 5) The instruction manual is usually placed inside the casing of the test kit or attached to the side of the casing so that the user can check it at any time.

[0113] 6. Component coordination

[0114] 1) The user first takes out the required reagents from the reagent tank according to the instructions in the manual, and uses a pipette or dropper to add the reagents to the sample tube placed in the sample tank.

[0115] 2) After adding the reagent, the user places the sample tube in the reaction area and waits for the sample to react with the reagent. At this time, the user can observe the reaction process through the transparent material of the reaction area.

[0116] 3) After the reaction is completed, the user refers to the instructions again and judges the test results based on the observed reaction conditions (such as color changes, fluorescence intensity, etc.).

[0117] 4) Finally, the user can properly dispose of used reagent bottles, sample tubes and other components as needed, and return the components of the test kit to their original locations for next use.

[0118] During the whole process, all parts work together to achieve fast and easy detection of samples. At the same time, the reasonable position design and connection relationship ensure the stability and convenience of the test kit during use.

[0119] Figure 3 Example of a box plot of test results.

[0120] Figure 4 Example of a box plot of test results.

[0121] Figure 5 An example of a scatter plot of the detection results.

[0122] The specific application fields or related products of the present invention.

[0123] 1. Scientific research application: Apelin detection kit is mainly used for in vitro quantitative detection of the concentration of Apelin protein in human serum, plasma or other related biological fluids. The kit uses enzyme-linked immunosorbent assay (ELISA) technology, which has high sensitivity and specificity, and can accurately detect human Apelin protein in samples, and has no obvious cross-reaction with its analogs.

[0124] 2. Clinical application: It can be used to predict the risk of DR in clinical diabetic patients. The mechanism of action of Apelin in various diseases such as diabetes is an important topic in the medical field. Therefore, the Apelin detection kit has potential application value in clinical practice.

[0125] 3. Product Features: Apelin detection kits have high sensitivity and specificity and can accurately detect human Apelin protein in samples. For example, some kits have high sensitivity and a wide detection range.

[0126] Preliminary studies of the present invention showed that: ① apelin expression in the vitreous humor of DME patients was significantly increased; ② apelin promoted the proliferation and migration of Muller cells, HRMECs and RPE, reduced Muller cell apoptosis and promoted Muller cell fibrosis; ③ apelin promoted the phosphorylation of the cytoskeleton and tight junction proteins of HRMEC and RPE; ④ apelin played a role in regulating cell activity and vascular leakage through the JAK / STAT, PI3K / Akt and MAPK / Erk1 / 2 signaling pathways.

[0127] 1.1 Clinical part

[0128] Apelin expression is significantly increased in the vitreous humor of DME patients (Yang Li, Yu-jing Bai, Li Chen, Wen-zhen Yu, Xuan Shi, Jing Feng, Gui-bo Sun, Yan-rong Jiang: Apelin-13 is an Early Promoter of Vascular Permeability in Diabetic Macular Edema via PI-3K / Akt and MAPK / Erk Signaling Pathways. Biomed Research International.)

[0129] Western blot results showed that the expression of apelin in vitreous fluid of patients with diabetic macular edema (DME) was significantly higher than that in patients with epiretinal membrane (ERM). Figure 6 B).

[0130] 1.2 Cellular Part

[0131] (1) Apelin promotes the phosphorylation level of HRMEC cytoskeleton and tight junction proteins through PI3K / Akt and MAPK / Erk signaling pathways (Yang Li, Yu-jing Bai, Li Chen, Wen-zhen Yu, Xuan Shi, Jing Feng, Gui-bo Sun, Yan-rong Jiang: Apelin-13 is an Early Promoter of Vascular Permeability in Diabetic Macular Edema via PI-3K / Akt and MAPK / Erk Signaling Pathways. Biomed Research International.)

[0132] 1) Apelin can promote the proliferation and migration of HRMEC and the phosphorylation expression of cytoskeleton and tight junction proteins under normal conditions

[0133] MTS cell proliferation assay showed that compared with the control group, exogenous apelin at 1, 10, 100, and 1000 ng / ml stimulated HRMEC for 24 hours, which could significantly promote the proliferation of HRMEC. Transwell chamber assay confirmed that compared with the control group, exogenous apelin at 1, 10, 100, and 1000 ng / ml stimulated HRMEC for 24 hours, which could significantly promote the migration of HRMEC. Immunofluorescence results showed that the phosphorylation expression of HRMEC cytoskeleton protein VE-Cadherin increased significantly after adding different concentrations of apelin. We selected two optimal concentrations of stimulation (10 and 100 ng / mL) for western blot detection, and the results showed that with the increase of apelin concentration, the phosphorylation levels of HRMEC cytoskeleton protein FAK, Src and tight junction protein occludin increased significantly.

[0134] 2) High glucose can promote the phosphorylation level of HRMEC apelin, cytoskeleton and tight junction proteins

[0135] RT-PCR results showed that compared with normal sugar concentration culture, the phosphorylation levels of apelin-13, APJ and skeleton proteins VE-Cadherin, FAK, and Src in HRMEC cells cultured under medium concentration (15.5mmol / mL) and high sugar (25mmol.mL) conditions were significantly increased, indicating that high glucose stimulation can promote the phosphorylation changes of the HRMEC cytoskeleton structure. Immunofluorescence results showed that with the increase of glucose concentration in the culture medium, the expression of apelin-13 in HRMEC cells was significantly enhanced, and western blot results also confirmed that the phosphorylation expression of HRMEC cytoskeleton proteins VE-Cadherin, FAK, Src and APJ proteins was also significantly increased.

[0136] 3) F13A, an inhibitor of apelin receptor APJ, can inhibit HRMEC proliferation and migration and the phosphorylation levels of cytoskeleton and tight junction proteins under high glucose conditions

[0137] MTS cell proliferation assay showed that compared with the control group, 0.2, 2, 20, 200 ng / ml F13A stimulated HRMEC for 24 hours, which could significantly inhibit the proliferation of HRMEC; Transwell chamber assay confirmed that compared with the control group, 0.2, 2, 20, 200 ng / ml F13A stimulated HRMEC for 24 hours, which could significantly reduce the migration ability of HRMEC. Immunofluorescence results showed that after 48 hours of high glucose stimulation of HRMEC, the phosphorylation levels of tight junction protein ZO-1 and Occludin protein in HRMEC cells also increased significantly. After 24 hours of culture with F13A, the phosphorylation expression of the measured proteins decreased significantly, indicating that apelin-13 promoted the phosphorylation of HRMEC cytoskeleton and tight junction protein under high glucose conditions, and F13A inhibited their expression. Two optimal concentrations of F13A stimulation (2 and 20 ng / mL) were selected for western blot detection. The results showed that with the increase of F13A concentration, the phosphorylation levels of HRMEC cytoskeletal protein FAK and tight junction protein Occludin were significantly decreased.

[0138] 4) Apelin promotes the phosphorylation expression of HRMEC cytoskeleton and tight junction proteins through PI3K / Akt and MAPK / Erk signaling pathways

[0139] Western blot results confirmed that under normal conditions, with the increase of apelin-13 concentration, the phosphorylation expression of PLCγ1, p38, Akt and Erk proteins in the PI-3K / Akt and MAPK / Erk signaling pathways increased significantly, and with the increase of sugar concentration, the phosphorylation expression of PLCγ1, p38, Akt and Erk also increased significantly. Under high sugar conditions, the addition of F13A significantly inhibited the phosphorylation levels of PLCγ1, p38, Akt and Erk proteins in the PI-3K / Akt and MAPK / Erk signaling pathways, indicating that apelin-13 promoted the phosphorylation of the HRMEC cytoskeleton and tight junction proteins through the PI-3K / Akt and MAPK / Erk signaling pathways.

[0140] (2) Apelin promotes the phosphorylation expression of RPE cytoskeleton and tight junction proteins through PI3K / Akt and MAPK / Erk signaling pathways (Yang Li, Yu-Jing Bai, Yan-Rong Jiang. Apelin induces the proliferation, migration and expression of cytoskeleton and tight junction proteins in human RPE cells via PI-3K / Akt and MAPK / Erk signaling pathways. Int J Clin Exp Pathol 2017; 10(11): 10711-10729.)

[0141] 1) Apelin can promote the proliferation and migration of RPE under normal conditions

[0142] The MTS cell proliferation experiment found that compared with the control group, 1, 10, 100, and 1000 ng / ml of exogenous apelin stimulated RPE for 24 hours could significantly promote the proliferation ability of RPE; the Transwell chamber experiment confirmed that compared with the control group, 1, 10, 100, and 1000 ng / ml of exogenous apelin stimulated RPE for 24 hours could significantly promote the migration ability of RPE.

[0143] 2) Apelin can promote the phosphorylation expression of RPE apelin, cytoskeleton and tight junction proteins

[0144] QRT-PCR results showed that the phosphorylation expression of RPE cytoskeleton proteins FAK and Src and tight junction proteins ZO-1 and occludin in apelin-treated RPE cells was significantly increased, indicating that apelin stimulation can promote the phosphorylation level of RPE cytoskeleton and tight junction proteins. Laser confocal scanning detection results showed that the phosphorylation expression of tight junction proteins occludin and ZO-1 in RPE cells gradually increased with the increase of apelin-13 concentration. At the same time, western blot results also confirmed that the phosphorylation levels of RPE cytoskeleton proteins FAK and Src and tight junction proteins ZO-1 and occludin were also significantly increased.

[0145] 3) F13A can inhibit the proliferation and migration of RPE cells under high glucose conditions

[0146] The MTS cell proliferation experiment found that after 48 hours of high-glucose culture, compared with the control group, 0.2, 2, 20, and 200 ng / ml exogenous F13A stimulation of RPE for 24 hours could significantly inhibit the proliferation ability of RPE; the Transwell chamber experiment confirmed that compared with the control group, 0.2, 2, 20, and 200 ng / ml exogenous F13A stimulation of RPE for 24 hours could significantly inhibit the migration ability of RPE.

[0147] 4) F13A can inhibit the phosphorylation expression of RPE cytoskeleton and tight junction proteins under high glucose conditions

[0148] The results of laser confocal scanning showed that after 48 hours of high glucose stimulation of RPE, F13A (0, 0.2, 2, 20, 200 ng / ml) was added for 24 hours, and the phosphorylation expression of tight junction proteins ZO-1 and occludin in RPE cells was significantly reduced, indicating that F13A inhibited their phosphorylation expression. The results of Western blot showed that with the increase of F13A concentration, the phosphorylation expression of RPE cytoskeleton proteins FAK and Src and tight junction proteins ZO-1 and occludin was also significantly reduced.

[0149] 5) Apelin promotes the phosphorylation expression of RPE cytoskeleton and tight junction proteins through PI3K / Akt and MAPK / Erk signaling pathways

[0150] Western blot results confirmed that under normal conditions, with the increase of apelin concentration, the expression of PI-3K / Akt and MAPK / Erk signaling pathway proteins PLCγ1, p38, Akt and Erk increased significantly. Under high glucose culture conditions, the addition of F13A significantly inhibited the expression of PI-3K / Akt and MAPK / Erk signaling pathway proteins PLCγ1, p38, Akt and Erk. Pretreatment of RPE with PI-3K inhibitor PD98059 and MAPK inhibitor LY294002 inhibited the expression of Akt and Erk, while the expression of both proteins increased significantly after apelin stimulation, indicating that apelin promoted the cytoskeleton and tight junction proteins of RPE through the PI-3K / Akt and MAPK / Erk signaling pathways.

[0151] (3) Apelin promotes the occurrence and development of Müller cell fibrosis in high glucose culture and retinal DR rats through the JAK2 / STAT3 signaling pathway (Li Y, Hu Q, Wang B. Effects of Apelin on the fibrosis of retinal tissues and Müller cells in diabetes retinopathy through the JAK2 / STAT3 signaling pathway. Autoimmunity. 2023 Dec; 56(1): 2259129. doi: 10.1080 / 08916934.2023.2259129. Epub 2023 Sep 28. PMID: 37771168.)

[0152] 1) Apelin promotes the production of extracellular matrix in Muller cells cultured in high glucose ( Figure 7 ), while knocking down apelin inhibits the production of extracellular matrix ( Figure 8 ).

[0153] After Muller cells were exposed to HG, Apelin protein levels were significantly upregulated in a time-dependent manner ( Figure 7 AB). In addition, the protein levels of GFAP, type I collagen, and α-SMA were also significantly upregulated in a time-dependent manner in HG-cultured Muller cells ( Figure 7 CF).

[0154] After si-Apelin 1# and 2# transfection, Apelin mRNA and protein levels were significantly downregulated ( Figure 8 AC), si-Apelin1# was selected for the next experiment due to its better transfection efficiency. Subsequently, we found that Apelin knockdown significantly reduced the protein levels of GFAP, type I collagen, and α-SMA in HG-stimulated MIO-M1 cells ( Figure 8 DG).

[0155] 2) Apelin regulates Muller cell fibrosis through the JAK2 / STAT3 signaling pathway ( Fig. 9 , 10).

[0156] We explored the role of Apelin in cell growth and development related signaling pathways (JAK2 / STAT3, Wnt / β-catenin and NFκB). We found that Apelin significantly inhibited the JAK2 / STAT3 signaling pathway ( Fig. 9 AC), while Wnt / β-catenin ( Fig. 9DE) and NFκB ( Fig. 9 Therefore, we selected the JAK2 / STAT3 pathway for further study. Fig. 9 As shown in JL, HG stimulation significantly promoted the phosphorylation of JAK2 and STAT3 in MIO-M1 cells, indicating that the JAK2 / STAT3 signaling pathway was activated after HG stimulation. In addition, Apelin knockdown reduced the levels of phosphorylated JAK2 and STAT3 in HG-stimulated MIO-M1 cells, indicating that the JAK2 / STAT3 pathway was inhibited

[0157] After Apelin transfection, Apelin mRNA and protein levels were significantly upregulated ( Fig.10 AC). We then confirmed that Apelin overexpression enhanced the phosphorylation levels of JAK2 and STAT3 in Muller cells cultured under HG, while FLLL32 treatment significantly inhibited the phosphorylation levels of signaling pathway proteins ( Fig.10 DF). In addition, Apelin overexpression increased the production of GFAP, type I collagen, and α-SMA in HG-stimulated Muller cells, whereas FLLL32 treatment significantly reduced the expression of these proteins ( Fig.10 GJ).

[0158] 1.3 Animal parts

[0159] (1) Apelin promotes the phosphorylation expression of retinal skeleton proteins and tight junction proteins in DR mouse models through PI3K / Akt and MAPK / Erk signaling pathways (Yang Li, Yu-jing Bai, Li Chen, Wen-zhen Yu, Xuan Shi, Jing Feng, Gui-bo Sun, Yan-rong Jiang: Apelin-13 is an Early Promoter of Vascular Permeability in Diabetic Macular Edema via PI-3K / Akt and MAPK / Erk Signaling Pathways. Biomed Research International.)

[0160] The phosphorylation expression levels of cytoskeletal proteins VE-Cadherin, FAK, Src and tight junction proteins occludin and zo-1 in the retina of C57BL / 6 mice were detected 10 days after intravitreal injection of apelin-13 (10 and 100 ng / ml). Western blot results showed that compared with the control group, the phosphorylation of retinal cytoskeletal proteins VE-Cadherin, FAK, Src and tight junction proteins occludin and zo-1 in apelin-13 pretreated retina was significantly increased. At the same time, the phosphorylation expression levels of PI-3K / Akt and MAPK / Erk signaling pathway proteins PLCγ1, p38, Akt and Erk were also significantly increased.

[0161] (2) F13A inhibits the phosphorylation expression of cytoskeleton and tight junction proteins in the retina of db / db mice via PI-3K / Akt and MAPK / Erk signaling pathways (Yang Li, Yu-jing Bai, Li Chen, Wen-zhen Yu, Xuan Shi, Jing Feng, Gui-bo Sun, Yan-rong Jiang: Apelin-13 is an Early Promoter of Vascular Permeability in Diabetic Macular Edema via PI-3K / Akt and MAPK / Erk Signaling Pathways. Biomed Research International.)

[0162] F13A (20 ng / mL) was injected into the vitreous cavity of db / db mice at 1, 3, 6, and 9 months of age. Western blot results showed that F13A significantly inhibited the phosphorylation expression of retinal cytoskeleton proteins VE-Cadherin, FAK, Src and tight junction proteins occludin and zo-1 in db / db mice. At the same time, the phosphorylation expression levels of PI-3K / Akt and MAPK / Erk signaling pathway proteins PLCγ1, p38, Akt, and Erk were also significantly reduced.

[0163] (3) Apelin promotes fibrosis of Müller cells in DM rats (Li Y, Hu Q, Wang B. Effects of Apelin on the fibrosis of retinal tissues and Müller cells in diabetes retinopathy through the JAK2 / STAT3 signalling pathway. Autoimmunity. 2023 Dec; 56(1): 2259129. doi: 10.1080 / 08916934.2023.2259129. Epub 2023 Sep 28. PMID: 37771168.) Fig.11 , 12)

[0164] HE staining results showed that epiretinal fibrotic membranes were observed in DM rats at 8 and 16 weeks, and were less abundant in DM rats and control rats at 4 weeks ( Fig.11 In addition, immunofluorescence ( Fig.11 B) and Western blot ( Fig.11 CD) analysis showed that apelin levels in diabetic rats were significantly increased in a time-dependent manner. In addition, GFAP, type I collagen, and α-SMA protein levels were significantly increased in the retinal tissue of diabetic rats from 4 to 16 weeks ( Fig.11 EH). In addition, we found that the vision of rats ( Fig.11 I) decreased significantly, contrast sensitivity ( Fig.11 J) increased significantly in a time-dependent manner.

[0165] After LV sh Apelin injection, Apelin levels in retinal tissue were significantly downregulated at both mRNA and protein levels ( Fig.12 AC). HE staining showed that knockout of Apelin alleviated the formation of fibrotic membrane in the retina of diabetic rats ( Fig.12 D). In addition, immunofluorescence staining results showed that Apelin knockout depleted the accumulation of Apelin in the retinal tissue of DM rats ( Fig.12 E). Immunohistochemical staining showed that after Aperin knockout, the upregulation of type I collagen level in the DM group was reduced ( Fig.12 F). After Apelin knockdown, the protein levels of GFAP, type I collagen and α-SMA in the retinal tissue of diabetic rats were significantly decreased ( Fig.12 GJ). In addition, we found that after knocking out Apelin, the visual acuity of DW rats was impaired ( Fig.12 K) and increased contrast sensitivity ( Fig.12 L) Significant reversal.

[0166] Thanks for watching the snowstorm:

[0167] Li Y,Hu Q,Wang B.Effects of apelin on the fibrosis of retinal tissuesand Müller cells in diabetic retinopathy through the JAK2 / STAT3 signalingpathway.Autoimmunity.2023Dec656(1):2259129.doi:10.1080 / 08916934.2023.2259129.Epub 2023Sep 28.PMID:37771168.

[0168] [ PMC free article ] [ PubMed ] [ Cross Ref ] Li Y, Bai YJ, Jiang YR, Yu WZ, Shi X, Chen L, Feng J, Sun GB Int.2018Apr4;2018:3242574.doi:10.1155 / 2018 / 3242574.PMID:29850504;PMCID:PMC5904819.

[0169] Li Y, Bai YJ, Jiang YR.Apelin induces the proliferation, migration andexpression of cytoskeleton and tight junction proteins in human RPE cells viaPI-3K / Akt and MAPK / Erk signaling pathways.Int J Clin Exp Pathol.2017Nov1010(11):10711-10729.PMID:31966415;PMCID:PMC6965848.

[0170] It should be noted that the embodiments of the present invention can be implemented by hardware, software, or a combination of software and hardware. The hardware part can be implemented using dedicated logic; the software part can be stored in a memory and executed by appropriate instructions, such as a microprocessor or dedicated design hardware. It can be understood by a person of ordinary skill in the art that the above-mentioned devices and methods can be implemented using computer executable instructions and / or contained in a processor control code, such as a carrier medium such as a disk, CD or DVD-ROM, a programmable memory such as a read-only memory (firmware), or a data carrier such as an optical or electronic signal carrier. Such code is provided on the carrier medium. The device and its modules of the present invention can be implemented by hardware circuits such as very large-scale integrated circuits or gate arrays, semiconductors such as logic chips, transistors, etc., or programmable hardware devices such as field programmable gate arrays, programmable logic devices, etc., can also be implemented by software executed by various types of processors, and can also be implemented by a combination of the above-mentioned hardware circuits and software, such as firmware.

[0171] The above description is only a specific implementation mode of the present invention, but the protection scope of the present invention is not limited thereto. Any modifications, equivalent substitutions and improvements made by any technician familiar with the technical field within the technical scope disclosed by the present invention and within the spirit and principle of the present invention should be covered by the protection scope of the present invention.

Claims

1. An Apelin detection kit detection method, characterized in that, The following steps are involved: Step 1, sample preparation: collect the sample to be tested according to the requirements of the instructions and place it in a dedicated sample tube to ensure the integrity and stability of the sample; Step 2, reagent addition: taking out a specific reagent from the kit and accurately adding it to the sample, so that the reagent specifically binds or reacts with the Apelin protein in the sample; Step 3, reaction and incubation: incubating the mixture of sample and reagent at a specific temperature to form an antigen-antibody complex of Apelin protein and antibody; Step 4, signal detection: measuring the signal generated by the marker through a detection device, the signal intensity of which is proportional to the concentration of Apelin in the sample; Step 5, result interpretation: Quantitatively analyze the detection signal to determine the concentration of Apelin in the sample.

2. The detection method of the Apelin detection kit according to claim 1, characterized in that: The organisms include blood and urine.

3. The detection method of the Apelin detection kit according to claim 1, characterized in that: The reagents are usually pre-formulated and have specific chemical properties to react with target substances in the sample.

4. The detection method of the Apelin detection kit according to claim 1, characterized in that: The reaction and incubation: After the reagents and samples are mixed, they need to be placed under appropriate conditions for reaction and incubation; the temperature and time parameters must be controlled to ensure that the reaction proceeds fully.

5. The detection method of the Apelin detection kit according to claim 1, characterized in that: The signal detection: After the reaction is completed, the presence of the target substance can be determined by observing the color change and fluorescence intensity signal in the sample tube.

6. The detection method of the Apelin detection kit according to claim 1, characterized in that: Interpretation of the results: Interpret the test results according to the standard curve or control table in the instructions; by comparing with the standard value, the concentration or activity level of the target substance in the sample can be determined, and the corresponding conclusion can be drawn.

7. An Apelin detection kit for implementing the detection method of the Apelin detection kit according to any one of claims 1 to 6, characterized in that: The Apelin detection kit detection system comprises: The sample preparation module is used to collect samples to be tested according to the requirements of the instructions; extract samples from organisms or the environment and place them in dedicated sample tubes; A reagent adding module, used to take out the corresponding reagent from the reagent kit and add it to the sample tube according to the instructions of the instruction manual; The reaction and incubation module is used to place the reagents and samples under appropriate conditions for reaction and incubation after they are mixed; the temperature and time parameters are controlled to ensure that the reaction proceeds fully; The signal detection module is used to determine the presence of the target substance by observing the color change and fluorescence intensity signal in the sample tube after the reaction is completed; The result interpretation module is used to interpret the test results according to the standard curve or reference table in the instruction manual; by comparing with the standard value, the concentration or activity level of the target substance in the sample can be determined, thereby drawing corresponding conclusions.

8. A computer device, characterized in that: The computer device includes a memory and a processor, wherein the memory stores a computer program, and when the computer program is executed by the processor, the processor executes the steps of the detection method of the Apelin detection kit according to any one of claims 1 to 6.

9. A computer-readable storage medium storing a computer program, wherein when the computer program is executed by a processor, the processor executes the steps of the detection method of the Apelin detection kit according to any one of claims 1 to 6.

10. An information data processing terminal, characterized in that: The information data processing terminal is used to implement the Apelin detection kit detection system as described in claim 7.